INCLINE VILLAGE, Nev., March 24 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq:PDLI - News) today announced that the cost basis for shares of Facet Biotech Corporation (Facet) (Nasdaq:FACT - News) distributed to PDL stockholders is $13.00, based on the closing price on the first day that Facet traded, December 19, 2008. On December 18, 2008, PDL made a stock distribution of one share of common stock of Facet Biotech Corporation (Facet) for every five shares of PDL common stock.
